Sex Differences in Cancer Outcomes and Kidney Function
Author Information
Author(s): Shemilt Richard, Sullivan Michael K, Hanlon Peter, Jani Bhautesh D, De La Mata Nicole, Rosales Brenda, Elyan Benjamin M P, Hedley James A, Cutting Rachel B, Wyld Melanie, McAllister David A, Webster Angela C, Mark Patrick B, Lees Jennifer S
Primary Institution: University of Glasgow
Hypothesis
The odds of presenting with advanced cancer may vary according to differences in estimated glomerular filtration rate (eGFR), contributing to increased all-cause mortality, with potential sex differences.
Conclusion
Lower or higher eGFR was associated with reduced survival, with a stronger association with all-cause mortality in females compared to males with eGFR <30.
Supporting Evidence
- eGFR <30 was associated with higher odds of presenting with advanced cancer of prostate, breast, and female genital organs.
- All-cause mortality was increased in all participants with eGFR <30, with a stronger association in females.
- Females with eGFR <45 were more likely to present with advanced breast and female genital tract cancers.
- Extremes of eGFR (both higher and lower) are associated with reduced survival in people diagnosed with cancer.
- Females with eGFR <30 had disproportionately higher hazards of death compared to males.
Takeaway
People with kidney problems might get more serious cancers, and women with very low kidney function might not live as long after a cancer diagnosis compared to men.
Methodology
Data were analyzed from a primary care database, using logistic regression models to determine odds of advanced cancer presentation and Cox proportional hazards models for all-cause mortality.
Potential Biases
Potential reverse causality exists as some cancers may impair kidney function, affecting eGFR.
Limitations
The study only included patients with at least two kidney function measures prior to cancer diagnosis, which may not represent all cancer patients.
Participant Demographics
The cohort included 46.7% females, with a mean age of 69.9 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
HR 1.71, 95% CI 1.56–1.88
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website